Skip to Content

New Drug Applications Archive - March 2012

Get news by email or subscribe to our news feeds.

March 1, 2012

U.S. Food and Drug Administration Extends Action Date for Eliquis (apixaban) by Three Months

March 5, 2012

FDA Accepts Resubmission of Perampanel New Drug Application

March 8, 2012

Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344

March 21, 2012

Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas

March 26, 2012

MAP Pharmaceuticals Receives Complete Response Letter from FDA for Levadex (dihydroergotamine) NDA

March 28, 2012

Chelsea Therapeutics Receives Complete Response Letter from Food and Drug Administration for Northera (droxidopa) Capsules

March 29, 2012

Genzyme and Isis Announce Submission of U.S. NDA for Kynamro (mipomersen sodium) in Homozygous Familial Hypercholesterolemia

New Drug Applications Archive

2017

January, February, March, April, May, June, July

2016

January, February, March, April, May, June, July, August, September, October, November, December

2015

January, February, March, April, May, June, July, August, September, October, November, December

2014

January, February, March, April, May, June, July, August, September, October, November, December

2013

January, February, March, April, May, June, July, August, September, October, November, December

2012

January, February, March, April, May, June, July, August, September, October, November, December

2011

January, February, March, April, May, June, July, August, September, October, November, December

2010

January, February, March, April, May, June, July, August, September, October, November, December

2009

January, February, March, April, May, June, July, August, September, October, November, December

2008

January, February, March, April, May, June, July, August, September, October, November, December

2007

January, February, March, April, May, June, July, August, September, October, November, December

2006

January, February, March, April, May, June, July, August, September, October, November, December

2005

January, February, March, April, May, June, July, August, September, October, November, December

2004

January, February, March, April, May, June, July, August, September, October, November, December

More News Resources

FDA Consumer Updates

More FDA updates

Recently Approved

Tremfya Tremfya (guselkumab) is an interleukin-23 blocker indicated for the treatment of moderate-to-severe...
Endari Endari (L-glutamine) is orally-administered pharmaceutical grade L-glutamine (PGLG), an amino acid...
Triptodur Triptodur (triptorelin) is a gonadotropin releasing hormone (GnRH) agonist indicated for the...
Bevyxxa Bevyxxa (betrixaban) is an oral, once-daily Factor Xa inhibitor anticoagulant for the...

Drugs.com Pill Reminder

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated July 5th, 2017), Cerner Multum™ (updated July 13th, 2017), Wolters Kluwer™ (updated July 5th, 2017) and others. To view content sources and attributions, please refer to our editorial policy.